We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pediatric contributions and lessons learned from the NEPTUNE cohort study.
- Authors
Modi, Zubin J.; Zhai, Yan; Yee, Jennifer; Desmond, Hailey; Hao, Wei; Sampson, Matthew G.; Sethna, Christine B.; Wang, Chia-shi; Gipson, Debbie S.; Trachtman, Howard; Kretzler, Matthias; Massengill, Susan; Lo, Layla; Dell, Katherine; O'Toole, John; Sedor, John; Martin, Blair; Macumber, Ian; Sharma, Silpa; Srivastava, Tarak
- Abstract
Primary glomerular diseases are rare entities. This has hampered efforts to better understand the underlying pathobiology and to develop novel safe and effective therapies. NEPTUNE is a rare disease network that is focused on patients of all ages with minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy. It is a longitudinal cohort study that collects detailed demographic, clinical, histopathologic, genomic, transcriptomic, and metabolomic data. The goal is to develop a molecular classification for these disorders that supersedes the traditional pathological features-based schema. Pediatric patients are important contributors to this ongoing project. In this review, we provide a snapshot of the children and adolescents enrolled in NEPTUNE and summarize some key observations that have been made based on the data accumulated during the study. In addition, we describe the development of NEPTUNE Match, a program that aims to leverage the multi-scalar information gathered for each individual patient to provide guidance about potential clinical trial participation based on the molecular characterization and non-invasive biomarker profile. This represents the first organized effort to apply principles of precision medicine to the treatment of patients with primary glomerular disease. NEPTUNE has proven to be an invaluable asset in the study of glomerular diseases in patients of all ages including children and adolescents.
- Subjects
NEPHROTIC syndrome treatment; BIOPSY; GENOMICS; TREATMENT effectiveness; FOCAL segmental glomerulosclerosis; NEPHROTIC syndrome; GLOMERULONEPHRITIS; MEDICAL research; GENE expression profiling; INDIVIDUALIZED medicine; METABOLOMICS; BIOMARKERS; KIDNEY glomerulus; CHILDREN
- Publication
Pediatric Nephrology, 2024, Vol 39, Issue 9, p2555
- ISSN
0931-041X
- Publication type
Article
- DOI
10.1007/s00467-023-06256-7